机构：[1]Peking Univ, Med Isotopes Res Ctr, Beijing, Peoples R China[2]Hebei Med Univ, Hosp 4, Dept Nucl Med, Shijiazhuang, Hebei, Peoples R China医技科室核医学科河北医科大学第四医院[3]Hebei Med Univ, Hosp 4, Dept Resp Med, Shijiazhuang, Hebei, Peoples R China临床科室呼吸内科河北医科大学第四医院
出处：
ISSN：
基金：
Science and Technology Department of Hebei Province, China [15277776D]
第一作者机构：[2]Hebei Med Univ, Hosp 4, Dept Nucl Med, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714)：
Zhang Zhaoqi,Zhao Xinming,Ding Cuimin,et al.(99m)Tc-3PRGD2 SPECT/CT Imaging for Monitoring Early Response of EGFR-TKIs Therapy in Patients with Advanced-Stage Lung Adenocarcinoma[J].JOURNAL OF NUCLEAR MEDICINE.2016,57:
APA：
Zhang, Zhaoqi,Zhao, Xinming,Ding, Cuimin,Wang, Jianfang,Zhang, Jingmian&Wang, Fan.(2016).(99m)Tc-3PRGD2 SPECT/CT Imaging for Monitoring Early Response of EGFR-TKIs Therapy in Patients with Advanced-Stage Lung Adenocarcinoma.JOURNAL OF NUCLEAR MEDICINE,57,
MLA：
Zhang, Zhaoqi,et al."(99m)Tc-3PRGD2 SPECT/CT Imaging for Monitoring Early Response of EGFR-TKIs Therapy in Patients with Advanced-Stage Lung Adenocarcinoma".JOURNAL OF NUCLEAR MEDICINE 57.(2016)
医学